alexa Individual Risk Detection of Developing Cognitive Decline and Dementia in Adults with Downand#8217;s Syndrome | OMICS International| Abstract

ISSN: 2472-1115

Journal of Down Syndrome & Chromosome Abnormalities

  • Review Article   
  • J Down Syndr Chr Abnorm 2017, Vol 3(1): 1
  • DOI: 10.4172/2472-1115.1000117

Individual Risk Detection of Developing Cognitive Decline and Dementia in Adults with Down’s Syndrome

Federico Licastro* and Elisa Porcellini
Department of Experimental, Diagnostic and Specialty Medicine, School of Medicine, University of Bologna, 40126 Bologna, Italy
*Corresponding Author : Federico Licastro, Laboratory of Immunopathology and Immunogenetics, Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Via S. Giacomo 14, 40126 Bologna, Italy, Tel: +39 051-2094730, Email: [email protected]

Received Date: Dec 23, 2016 / Accepted Date: Feb 22, 2017 / Published Date: Feb 28, 2017


Alzheimer’s disease (AD) is a neurodegenerative brain alteration and a leading cause of cognitive decline and dementia and incidence and prevalence of AD are increasing in both industrial and rural societies. However, in spite of intensive research during last thirty years no effective medication is available. Neuropathological AD hallmarks are amyloid deposition and neurofibrillary tangles, however, presence of these brian deposits do not completely explain the disease’s pathogenesis. Recently Aβ peptide, the proteinaceous precursor of brain amyloid deposits, has been proposed as an anti-microbial factor. Recent investigations have indeed shown that virus and/or bacterial infections influenced the clinical history of AD. Genotypic, phenotypic, epidemiological and clinical variables have been associated with an increased risk of cognitive decline or dementia as assesed by longitudinal population investigations. For instance, our data suggested that some genetic signatures, as shown by the AD genome wide association studies, might decrease host antimicrobial immune responses and affect progression to clinical dementia in the elderly by increasing susceptibility to herpes virus infections. The aim of this commentary is to briefly show innovative applicative procedures to determine individual risk of dementia and the possibility to modulate cognitive decline/dementia risk by personalized preventive interventions. The approach presented here may have clinical relevance in adult people with Down’s syndrome that are considered at elevated risk of developing cognitive decline and senile dementia after their 50’ths of age.

Keywords: Down’s syndrome; Cognitive deterioration; Dementia risk chart, Alzheimer’s disease; Herpes virus latent infections; Peripheral inflammation.

Citation: Licastro F, Porcellini E (2017) Individual Risk Detection of Developing Cognitive Decline and Dementia in Adults with Down’s Syndrome. J Down Syndr Chr Abnorm 3: 117. Doi: 10.4172/2472-1115.1000117

Copyright: © 2017 Licastro F, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Select your language of interest to view the total content in your interested language

Post Your Comment
Share This Article
Relevant Topics
Recommended Conferences
Article Usage
  • Total views: 632
  • [From(publication date): 0-2017 - May 25, 2018]
  • Breakdown by view type
  • HTML page views: 562
  • PDF downloads: 70
Leave Your Message 24x7